SCHEMBL4286723

SCHEMBL4286723

CCCOc1ccc(C(=O)c2c(F)cc(C)cc2OC(C)=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.44
PLK1 P53350 1/20 0.44
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 3/20 0.41
THRB P10828 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HTT P42858 2/20 0.39
CYP2C9 P11712 1/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP19A1 P11511 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
ELANE P08246 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4282847 0.90 KMT2A (0.46) L3MBTL1PLK1ALDH1A1MAPTNPC1
SCHEMBL4280964 0.84 SLC5A1 (0.47) L3MBTL1PLK1CYP1A2CYP2C19ALDH1A1
SCHEMBL4287208 0.83 BACE1 (0.49) CYP2C19ALDH1A1MAPTNPC1RAB9A
SCHEMBL4284608 0.80 KMT2A (0.44) ALDH1A1MAPTRAB9AKDM4ELMNA
SCHEMBL28781281 0.79 SLC5A1 (0.43) L3MBTL1PLK1CYP1A2CYP2C19ALDH1A1
SCHEMBL4282990 0.78 MAPT (0.46) L3MBTL1PLK1ALDH1A1MAPTNPC1
SCHEMBL13845293 0.75 ELANE (0.61) L3MBTL1PLK1HTTKDM4ESMN1; SMN2
SCHEMBL6341040 0.73 L3MBTL1 (0.68) L3MBTL1PLK1MAPTCYP19A1LMNA
SCHEMBL4284273 0.73 SLC5A1 (0.47) L3MBTL1PLK1ALDH1A1MAPTABCG2
SCHEMBL4292209 0.73 MAPT (0.51) L3MBTL1PLK1ALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 L3MBTL1 2087/4885PLK1 4871/4885CYP1A2 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.